Product image of Maxalt Smelt (Rizatriptan Benzoate) supplied by GNH India

Maxalt Smelt

Active Ingredient:
Rizatriptan Benzoate
Origin:
EU

Maxalt Smelt (Rizatriptan Benzoate)

Rizatriptan, the active ingredient in Maxalt Smelt, is a triptan presented as an oral tablet for oral use. It is employed for the acute treatment of migraine attacks in adults and works by targeting serotonin receptors to relieve headache pain and associated symptoms when taken at the onset of an attack.

GNH India supplies Maxalt Smelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare providers worldwide.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Rizatriptan is a selective 5‑HT1B/1D receptor agonist used in the acute treatment of migraine.
  • Migraine attack: provides rapid relief of headache and associated symptoms when taken at the onset of an attack.
  • Migraine with aura: reduces headache severity and associated neurological symptoms.
  • Menstrual migraine: helps alleviate headache during the menstrual cycle.

How It Works

  • Rizatriptan binds selectively to 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. Activation of these receptors causes vasoconstriction of dilated intracranial vessels and inhibits the release of pro‑inflammatory neuropeptides, thereby interrupting the migraine cascade and relieving pain.

Side Effects

Rizatriptan may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Chest discomfort or tightness
  • Throat tightness or pressure
  • Nausea or vomiting
  • Dizziness or light‑headedness
  • Tingling or numbness in the extremities
  • Fatigue or drowsiness

Serious or Rare Side Effects

  • Serotonin syndrome, especially when combined with other serotonergic agents
  • Coronary artery vasospasm leading to chest pain or myocardial ischemia
  • Severe allergic reactions such as anaphylaxis or angioedema

Precautions & Warnings

  • Before using Maxalt Smelt, consider the following safety measures.
  • Cardiovascular disease: assess risk and avoid use in uncontrolled coronary conditions.
  • History of stroke or transient ischemic attack: contraindicated.
  • Concomitant MAO‑inhibitors: avoid due to risk of serotonin syndrome.
  • Pregnancy: use only if the potential benefit justifies the potential risk to the fetus.
  • Drug interactions: review all serotonergic medications and adjust therapy as needed.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Rizatriptan can interact with several drug classes; monitoring and avoidance are recommended where appropriate.

Major Interactions (Avoid)

  • MAO inhibitors: increased risk of serotonin syndrome.
  • Other triptans or ergot derivatives: additive vasoconstrictive effects.
  • Certain anti‑migraine agents (e.g., dihydroergotamine): heightened cardiovascular risk.

Moderate Interactions (Monitor Closely)

  • SSRIs, SNRIs, or other serotonergic antidepressants: watch for signs of serotonin excess.
  • Antihypertensive agents: possible enhancement of blood‑pressure lowering effects.
  • Strong CYP3A4 inhibitors: may raise rizatriptan plasma concentrations.

Frequently Asked Questions

Maxalt Smelt contains rizatriptan and is prescribed for the acute treatment of migraine attacks in adults. It is taken at the first sign of a migraine to relieve headache pain and associated symptoms such as nausea, photophobia, and phonophobia.

Rizatriptan works by selectively stimulating serotonin 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve endings. This causes vasoconstriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade.

The dose of Maxalt Smelt is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety data for rizatriptan in pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To order Maxalt Smelt, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Rizatriptan (Maxalt Smelt) has a rapid onset of action, typically within 30 minutes, and a relatively short half‑life compared with some other triptans such as sumatriptan. Choice of triptan depends on individual response, tolerability, and physician preference; all share a similar mechanism of serotonin receptor agonism.

Store Maxalt Smelt tablets at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain stability.

Maxalt Smelt is taken orally as a tablet. Swallow the tablet whole with a glass of water. It may be taken with or without food, but patients should avoid excessive alcohol and follow any specific instructions from their prescriber.

Serious risks include chest pain or pressure, coronary vasospasm, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience severe chest discomfort, shortness of breath, or signs of an allergic reaction.

Maxalt Smelt is contraindicated in patients with uncontrolled cardiovascular disease, a history of myocardial infarction, stroke, or transient ischemic attack, and in those currently taking MAO inhibitors. It should also be avoided in patients with known hypersensitivity to rizatriptan or any tablet excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rizatriptan Benzoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT